LENZ Therapeutics, Inc. Q4 2025 Earnings Call Summary

Management attributes early success to real-world clinical performance matching trial data, with patients experiencing near-vision benefits within 30 minutes that last throughout the workday. The launch strategy prioritizes a 'sample-first' approach to drive natural self-selection, which management believes creates a more durable, sticky patient base despite a more gradual initial NRx ramp compared to historical category launches. Operational data indicates high productivity among top prescribers, wit ...